Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women

Marc J. Gunter, Donald R. Hoover, Herbert Yu, Sylvia Wassertheil-Smoller, Thomas E. Rohan, Joann E. Manson, Barbara V. Howard, Judith Wylie-Rosett, Garnet L. Anderson, Gloria Y F Ho, Robert C. Kaplan, Jixin Li, Xiaonan (Nan) Xue, Tiffany G. Harris, Robert D. Burk, Howard Strickler

Research output: Contribution to journalArticle

148 Citations (Scopus)

Abstract

Obesity is a risk factor for colorectal cancer, and hyperinsulinemia, a common condition in obese patients, may underlie this relationship. Insulin, in addition to its metabolic effects, has promitotic and antiapoptotic activity that may be tumorigenic. Insulin-like growth factor (IGF)-I, a related hormone, shares sequence homology with insulin, and has even stronger mitogenic effects. However, few prospective colorectal cancer studies directly measured fasting insulin, and none evaluated free IGF-I, or endogenous estradiol, a potential cofactor in postmenopausal women. Therefore, we conducted a case-cohort investigation of colorectal cancer among nondiabetic subjects enrolled in the Women's Health Initiative Observational Study, a prospective cohort of 93,676 postmenopausal women. Fasting baseline serum specimens from all incident colorectal cancer cases (n = 438) and a random subcohort (n = 816) of Women's Health Initiative Observational Study subjects were tested for insulin, glucose, total IGF-I, free IGF-I, IGF binding protein-3, and estradiol. Comparing extreme quartiles, insulin [hazard ratio (HR)q4-q1, 1.73; 95% confidence interval (CI), 1.16-2.57; Ptrend = 0.005], waist circumference (HRq4-q1, 1.82; 95% CI, 1.22-2.70; Ptrend = 0.001), and free IGF-I (HRq4-q1, 1.35; 95% CI, 0.92-1.98; P trend = 0.05) were each associated with colorectal cancer incidence in multivariate models. However, these associations each became nonsignificant when adjusted for one another. Endogenous estradiol levels, in contrast, were positively associated with risk of colorectal cancer (HR comparing high versus low levels, 1.53; 95% CI, 1.05-2.22), even after control for insulin, free IGF-I, and waist circumference. These data suggest the existence of at least two independent biological pathways that are related to colorectal cancer: one that involves endogenous estradiol, and a second pathway broadly associated with obesity, hyperinsulinemia, and free IGF-I.

Original languageEnglish (US)
Pages (from-to)329-337
Number of pages9
JournalCancer Research
Volume68
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Insulin-Like Growth Factor I
Colorectal Neoplasms
Estradiol
Insulin
Confidence Intervals
Hyperinsulinism
Waist Circumference
Women's Health
Observational Studies
Fasting
Obesity
Insulin-Like Growth Factor Binding Protein 3
Sequence Homology
Hormones
Glucose
Incidence
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. / Gunter, Marc J.; Hoover, Donald R.; Yu, Herbert; Wassertheil-Smoller, Sylvia; Rohan, Thomas E.; Manson, Joann E.; Howard, Barbara V.; Wylie-Rosett, Judith; Anderson, Garnet L.; Ho, Gloria Y F; Kaplan, Robert C.; Li, Jixin; Xue, Xiaonan (Nan); Harris, Tiffany G.; Burk, Robert D.; Strickler, Howard.

In: Cancer Research, Vol. 68, No. 1, 01.01.2008, p. 329-337.

Research output: Contribution to journalArticle

Gunter, Marc J. ; Hoover, Donald R. ; Yu, Herbert ; Wassertheil-Smoller, Sylvia ; Rohan, Thomas E. ; Manson, Joann E. ; Howard, Barbara V. ; Wylie-Rosett, Judith ; Anderson, Garnet L. ; Ho, Gloria Y F ; Kaplan, Robert C. ; Li, Jixin ; Xue, Xiaonan (Nan) ; Harris, Tiffany G. ; Burk, Robert D. ; Strickler, Howard. / Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. In: Cancer Research. 2008 ; Vol. 68, No. 1. pp. 329-337.
@article{20fc6e565c1549a385ef93639dfd89b8,
title = "Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women",
abstract = "Obesity is a risk factor for colorectal cancer, and hyperinsulinemia, a common condition in obese patients, may underlie this relationship. Insulin, in addition to its metabolic effects, has promitotic and antiapoptotic activity that may be tumorigenic. Insulin-like growth factor (IGF)-I, a related hormone, shares sequence homology with insulin, and has even stronger mitogenic effects. However, few prospective colorectal cancer studies directly measured fasting insulin, and none evaluated free IGF-I, or endogenous estradiol, a potential cofactor in postmenopausal women. Therefore, we conducted a case-cohort investigation of colorectal cancer among nondiabetic subjects enrolled in the Women's Health Initiative Observational Study, a prospective cohort of 93,676 postmenopausal women. Fasting baseline serum specimens from all incident colorectal cancer cases (n = 438) and a random subcohort (n = 816) of Women's Health Initiative Observational Study subjects were tested for insulin, glucose, total IGF-I, free IGF-I, IGF binding protein-3, and estradiol. Comparing extreme quartiles, insulin [hazard ratio (HR)q4-q1, 1.73; 95{\%} confidence interval (CI), 1.16-2.57; Ptrend = 0.005], waist circumference (HRq4-q1, 1.82; 95{\%} CI, 1.22-2.70; Ptrend = 0.001), and free IGF-I (HRq4-q1, 1.35; 95{\%} CI, 0.92-1.98; P trend = 0.05) were each associated with colorectal cancer incidence in multivariate models. However, these associations each became nonsignificant when adjusted for one another. Endogenous estradiol levels, in contrast, were positively associated with risk of colorectal cancer (HR comparing high versus low levels, 1.53; 95{\%} CI, 1.05-2.22), even after control for insulin, free IGF-I, and waist circumference. These data suggest the existence of at least two independent biological pathways that are related to colorectal cancer: one that involves endogenous estradiol, and a second pathway broadly associated with obesity, hyperinsulinemia, and free IGF-I.",
author = "Gunter, {Marc J.} and Hoover, {Donald R.} and Herbert Yu and Sylvia Wassertheil-Smoller and Rohan, {Thomas E.} and Manson, {Joann E.} and Howard, {Barbara V.} and Judith Wylie-Rosett and Anderson, {Garnet L.} and Ho, {Gloria Y F} and Kaplan, {Robert C.} and Jixin Li and Xue, {Xiaonan (Nan)} and Harris, {Tiffany G.} and Burk, {Robert D.} and Howard Strickler",
year = "2008",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-07-2946",
language = "English (US)",
volume = "68",
pages = "329--337",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women

AU - Gunter, Marc J.

AU - Hoover, Donald R.

AU - Yu, Herbert

AU - Wassertheil-Smoller, Sylvia

AU - Rohan, Thomas E.

AU - Manson, Joann E.

AU - Howard, Barbara V.

AU - Wylie-Rosett, Judith

AU - Anderson, Garnet L.

AU - Ho, Gloria Y F

AU - Kaplan, Robert C.

AU - Li, Jixin

AU - Xue, Xiaonan (Nan)

AU - Harris, Tiffany G.

AU - Burk, Robert D.

AU - Strickler, Howard

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Obesity is a risk factor for colorectal cancer, and hyperinsulinemia, a common condition in obese patients, may underlie this relationship. Insulin, in addition to its metabolic effects, has promitotic and antiapoptotic activity that may be tumorigenic. Insulin-like growth factor (IGF)-I, a related hormone, shares sequence homology with insulin, and has even stronger mitogenic effects. However, few prospective colorectal cancer studies directly measured fasting insulin, and none evaluated free IGF-I, or endogenous estradiol, a potential cofactor in postmenopausal women. Therefore, we conducted a case-cohort investigation of colorectal cancer among nondiabetic subjects enrolled in the Women's Health Initiative Observational Study, a prospective cohort of 93,676 postmenopausal women. Fasting baseline serum specimens from all incident colorectal cancer cases (n = 438) and a random subcohort (n = 816) of Women's Health Initiative Observational Study subjects were tested for insulin, glucose, total IGF-I, free IGF-I, IGF binding protein-3, and estradiol. Comparing extreme quartiles, insulin [hazard ratio (HR)q4-q1, 1.73; 95% confidence interval (CI), 1.16-2.57; Ptrend = 0.005], waist circumference (HRq4-q1, 1.82; 95% CI, 1.22-2.70; Ptrend = 0.001), and free IGF-I (HRq4-q1, 1.35; 95% CI, 0.92-1.98; P trend = 0.05) were each associated with colorectal cancer incidence in multivariate models. However, these associations each became nonsignificant when adjusted for one another. Endogenous estradiol levels, in contrast, were positively associated with risk of colorectal cancer (HR comparing high versus low levels, 1.53; 95% CI, 1.05-2.22), even after control for insulin, free IGF-I, and waist circumference. These data suggest the existence of at least two independent biological pathways that are related to colorectal cancer: one that involves endogenous estradiol, and a second pathway broadly associated with obesity, hyperinsulinemia, and free IGF-I.

AB - Obesity is a risk factor for colorectal cancer, and hyperinsulinemia, a common condition in obese patients, may underlie this relationship. Insulin, in addition to its metabolic effects, has promitotic and antiapoptotic activity that may be tumorigenic. Insulin-like growth factor (IGF)-I, a related hormone, shares sequence homology with insulin, and has even stronger mitogenic effects. However, few prospective colorectal cancer studies directly measured fasting insulin, and none evaluated free IGF-I, or endogenous estradiol, a potential cofactor in postmenopausal women. Therefore, we conducted a case-cohort investigation of colorectal cancer among nondiabetic subjects enrolled in the Women's Health Initiative Observational Study, a prospective cohort of 93,676 postmenopausal women. Fasting baseline serum specimens from all incident colorectal cancer cases (n = 438) and a random subcohort (n = 816) of Women's Health Initiative Observational Study subjects were tested for insulin, glucose, total IGF-I, free IGF-I, IGF binding protein-3, and estradiol. Comparing extreme quartiles, insulin [hazard ratio (HR)q4-q1, 1.73; 95% confidence interval (CI), 1.16-2.57; Ptrend = 0.005], waist circumference (HRq4-q1, 1.82; 95% CI, 1.22-2.70; Ptrend = 0.001), and free IGF-I (HRq4-q1, 1.35; 95% CI, 0.92-1.98; P trend = 0.05) were each associated with colorectal cancer incidence in multivariate models. However, these associations each became nonsignificant when adjusted for one another. Endogenous estradiol levels, in contrast, were positively associated with risk of colorectal cancer (HR comparing high versus low levels, 1.53; 95% CI, 1.05-2.22), even after control for insulin, free IGF-I, and waist circumference. These data suggest the existence of at least two independent biological pathways that are related to colorectal cancer: one that involves endogenous estradiol, and a second pathway broadly associated with obesity, hyperinsulinemia, and free IGF-I.

UR - http://www.scopus.com/inward/record.url?scp=39149111599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149111599&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-2946

DO - 10.1158/0008-5472.CAN-07-2946

M3 - Article

VL - 68

SP - 329

EP - 337

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 1

ER -